Ketamine suppresses proinflammatory cytokine production in human whole blood in vitro

Anesthesia and Analgesia

Volumn 89, Issue 3, 1999, Pages 665-669

  Kawasaki, Takashi ^a   Ogata, Masanori ^a   Kawasaki, Chika ^a   Ogata, Jun Ichi ^a   Inoue, Yoshitaka ^a   Shigematsu, Akio ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8; KETAMINE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD; CELL STIMULATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFECT; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL;

ANESTHETICS, DISSOCIATIVE; CELL SURVIVAL; CYTOKINES; ENDOTOXINS; ESCHERICHIA COLI; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; KETAMINE; LIPOPOLYSACCHARIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032845356     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199909000-00024     Document Type: Article

References (24)

1. Marshall WG, Dimick AR. Natural history of major burns with multiple subsystem organ failure. J Trauma 1983;23:102-5.
2. Goris RJA, Boekholtz WKF, van Bebber IPT, et al. Multiple organ failure and sepsis without bacteria. Arch Surg 1986;121: 897-901.
3. Marano MA, Fong Y, Moldawer LL, et al. Serum cachectin/ tumor necrosis factor in critically ill patients with burns correlates with infection and mortality. Surg Gynecol Obstet 1990; 170:32-8.
4. Meade P, Shoemaker WC, Donnelly TJ, et al. Temporal patterns of hemodynamics, oxygen transport, cytokine activity and complement activity in the development of adult respiratory distress syndrome after severe injury. J Trauma 1994;36:651-7.
5. Waage A, Brandtzaeg P, Halstensen A, et al. The complex pattern of cytokines in serum from patients with meningococcal septic shock. J Exp Med 1989;169:333-8.
6. Tracey KJ, Beutler B, Lowry SF, et al. Shock and tissue injury by recombinant human cachectin. Science 1986;234:470-4.
7. Lippmann M, Appel PL, Mok MS, Shoemaker WC. Sequential cardiorespiratory patterns of anesthetic induction with ketamine in critically ill patients. Crit Care Med 1983;11:730-4.
8. Yli-Hankala, Kirvela M, Randell T, et al. Ketamine anaesthsia in a patient with septic shock. Acta Anaesthsiol Scand 1992;36: 483-5.
9. Takenaka I, Ogata M, Koga K, et al. Ketamine suppresses endotoxin-induced tumor necrosis factor alpha production in mice. Anesthesiology 1994;80:402-8.
10. Koga K, Ogata M, Takenaka I, et al. Ketamine suppresses tumor necrosis factor-α activity and mortality in carrageenan-sensitized endotoxin shock model. Circ Shock 1995;44:160-8.
11. DeForge LE, Remick DG. Kinetics of TNF, IL-6, and IL-8 gene expression in LPS-stimulated human whole blood. Biochem Biophys Res Commun 1991;174:18-24.
12. 106-138-immunoglobulin G in whole blood. Infect Immunol 1997;65:2160-7.
13. Ruff MR, Gifford GE. Purification and physiochemical characterization of rabbit tumor necrosis factor. J Immunol 1980;125: 1671-7.
14. Desch CE, Kovach NL, Present W, et al. Production of human tumor necrosis factor from whole blood ex vivo. Lymphokine Res 1989;8:141-6.
15. Wright SD, Ramos RA, Tobias PS, et al. CD14, a receptor for complexes of LPS and LPS binding protein. Science 1990;249: 1431-3.
16. DeForge LE, Kenney JS, Jones ML, et al. Biphasic production of IL-8 in LPS-stimulated human whole blood. J Immunol 1992; 148:2133-41.
17. Bodai BI, Harms BA, Nottingham PB, et al. The effect of ketamine on endotoxin-induced lung injury. Anesth Analg 1983; 62:398-403.
18. Van der Linder P, Gilbart E, Engelman E, et al. Comparison of halothane, isoflurane, alfentanil, and ketamine in experimental septic shock. Anesth Analg 1990;70:608-17.
19. Domino EF, Zsigmond EK, Domino LE, et al. Plasma levels of ketamine and two of its metabolites in surgical patients using a gas chromatographic mass fragmentographic assay. Anesth Analg 1982;61:87-92.
20. Shimaoka M, Iida T, Ohara A, et al. Ketamine inhibits nitric oxide production in mouse-activated macrophage-like cells. Br J Anaesth 1996;77:238-42.
21. Li C-Y, Chou T-C, Wong C-S, et al. Ketamine inhibits nitric oxide synthase in lipopolysaccharide-treated rat alveolar macrophages. Can J Anaesth 1997;44:989-95.
22. Schmidt H, Ebeling D, Bauer H, et al. Ketamine attenuates endotoxin-induced leukocyte adherence in rat mesenteric venules. Crit Care Med 1995;23:2008-14.
23. Roytblat L, Talmor D, Rachinsky M, et al. Ketamine attenuates the interleukin-6 response after cardiopulmonary bypass. Anesth Analg 1998;87:266-71.
24. Roytblat L, Roy-Shapira A, Greemberg L, et al. Preoperative low dose ketamine reduces serum interleukin-6 response after abdominal hysterectomy. Pain Clin 1996;9:327-34.